跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
Philippines FDA
/
Rapamune
Approved
STANDARD
Rapamune
Pfizer Ireland Pharmaceuticals
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
17fe6502a9e63255
Company
Pfizer Ireland Pharmaceuticals
Type
Standard
Approval Details
Approval Id
17fe6502a9e63255
Drug Approval Philippines Name
Rapamune
Product Name
Rapamune
Registration Number
DR-XY27395
Brand Name
Rapamune
Generic Name
Sirolimus
Dosage Form
Sugar-Coated Tablet
Dosage Strength
1 mg
Manufacturer
Pfizer Ireland Pharmaceuticals
Importer
Pfizer, Inc.
Distributor
Pfizer Inc.
Company Detail Path
/organization/pfizer-ireland-pharmaceuticals
Importer Detail Path
/organization/pfizer-inc-pleasant-prairie-wisconsin-united-states
Distributor Detail Path
/organization/pfizer-inc
Issuance Date
25 July 2024
Expiry Date
23 September 2029
Pharmacologic Category
Immunosuppressant
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
17fe6502a9e63255
Type
Standard
Back to Philippines FDA Approvals
Rapamune - Philippines FDA Drug Approval Details